Lenvatinib Promotes the Antitumor Effect of Doxorubicin in Anaplastic Thyroid Cancer

PURPOSE: Anaplastic thyroid cancer (ATC) is a kind of rare thyroid cancer with very poor prognosis. Doxorubicin has been approved in ATC treatment as a single agent, but monotherapy still shows no improvement of the total survival in advanced ATC. Lenvatinib was investigated with encouraging results...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Xi, Liu, Jiaxin, Zhang, Haihong, Gu, Qingqing, Zhou, Xinrui, Ji, Meiju, Yao, Demao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646435/
https://www.ncbi.nlm.nih.gov/pubmed/33173310
http://dx.doi.org/10.2147/OTT.S278349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646435/
https://www.ncbi.nlm.nih.gov/pubmed/33173310
http://dx.doi.org/10.2147/OTT.S278349

Ejemplares similares